BeOne Medicines AG
Status: Publicly traded
Direct answer
BeOne Medicines AG is publicly traded on HKSE under the ticker 6160.HK.
BeiGene Ltd. is a global biotechnology enterprise, grounded in scientific research, committed to developing groundbreaking and economical pharmaceutical products. Its core mission is to enhance therapeutic outcomes and broaden patient access to critical medicines across the world. The company was co-founded by Xiao Dong Wang and John V. Oyler on October 28, 2010, and its corporate headquarters are situated in George...
Can you invest in BeOne Medicines AG?
Yes. BeOne Medicines AG trades publicly on HKSE as 6160.HK.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for BeOne Medicines AG
Detailed equity research is provided by MarketSnap.